ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Psychedelic Science 2025 Announces “Conscious Capitalism Workshop” Featuring “Heroic” and “Microdose” Pitch Opportunities for Visionary Startups

DENVER, June 05, 2025 (GLOBE NEWSWIRE) -- Psychedelic Science 2025 (PS2025), the world’s leading conference on psychedelic research, medicine, policy, and culture hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), today announced the addition of the Conscious Capitalism Workshop, a dynamic event blending education, investment insight, and two levels of live founder pitches: the Heroic Pitch and the Microdose Pitch.

This high-energy, interactive session, taking place on Monday, June 16, 2025, from 2:30 PM to 6:00 PM at the Colorado Convention Center, offers a rare behind-the-scenes look at the values-aligned startup journey in the psychedelic ecosystem. While informally referred to as the “Shark Tank” of PS2025, the session prioritizes mentorship over competition and integration over extraction. Attendees can hear first-hand from the “Sharks” on how they evaluate companies and what they consider when making investment decisions.

Workshop Format

  • VC 101 Roundtable: A candid conversation led by Lewis Goldberg, Partner at KCSA Strategic Communications, exploring how psychedelic investing works—covering capital strategy, founder readiness, and ethical funding decisions.
  • The Heroic Pitch: Select early-stage companies will deliver 10-minute pitches, followed by real-time investor feedback and shared insights.
  • The Microdose Pitch: In this rapid-fire format, any attendee can apply to deliver a concise 2–3 minute pitch to showcase their vision.
  • Networking Reception: The session concludes with cocktails and open networking to foster connection and collaboration.

Featured Conscious Capitalists

  • Simeon Schnapper, Managing Partner, JLS Fund
  • Shelby Clark, Partner, Lionheart Ventures; Founder, Turo
  • Amy Emerson, Former CEO, Lykos Therapeutics
  • Tim Regan, Analyst, Water Tower Research

These industry leaders bring deep experience in venture capital, biotech, therapeutics, and psychedelic infrastructure—and they are here not to judge, but to uplift and empower the next wave of impact entrepreneurs.

A Call to Action

“This workshop is more than timely—it’s essential. At a time when our nation faces an unprecedented mental health crisis, we can’t wait for institutional systems to catch up. The real breakthroughs—from technology to biotech—have always come from bold founders building from the ground up. Just look at the history—Intel, Meta, Moderna, Genentech. These weren’t top-down solutions. They were startups led by visionaries and backed by investors who saw the future before the market did. The PS2025 Conscious Capitalism Workshop is about giving today’s psychedelic pioneers the tools, insight, and access to become tomorrow’s impact giants.”
Lewis Goldberg, KCSA Partner and Moderator of the Conscious Capitalism Workshop

Apply for the Microdose Pitch

In a rare opportunity, applicants not selected for the Heroic Pitch can apply to participate in the Microdose Pitch—a rapid-fire, 2–3 minute live pitch in front of leading psychedelic investors and influencers. This will be a first come, first served opportunity.

No slides. No pressure. Just your story, your idea, and your three minutes.

To apply:
Email your name, company, and a short explanation of your pitch to PS2025@kcsa.com
Deadline: Monday, June 10, 2025, by 5:00 p.m. ET
Spots are limited. The value of this exposure is immeasurable.

More Than Capital — A Movement for Integration

The Conscious Capitalism Workshop reflects the overarching Psychedelic Science 2025 theme of The Integration, bridging science, spirituality, innovation, and investment. As psychedelic medicine evolves into a regulated industry, how we build it—and who we empower to lead—matters more than ever.

Visit PsychedelicScience.org to view full programming, register for workshops, and explore hotel and travel options. All Business workshops are included in the Business level registration and are available as add-ons on a limited basis.

About Psychedelic Science
Psychedelic Science 2025 (PS2025), hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), is the world’s leading psychedelic conference. Returning to the Colorado Convention Center in Denver from June 16-20, 2025, this five-day event brings together a global community of scientists, therapists, policymakers, cultural leaders, and advocates to explore the forefront of psychedelic research, therapy, and culture. Facilitated by Superfly, known for producing iconic events such as Bonnaroo and Outside Lands, PS2025 will feature expert speakers; hands-on workshops; community events with art, music, and mindfulness activities; and scholarship opportunities to support broad participation.

Since its inception in 2010, the Psychedelic Science conference series has fostered knowledge-sharing, collaboration, and community-building within the psychedelic ecosystem. Join thousands of attendees as we explore the transformative potential of psychedelics and shape the future of mental health, policy, and cultural understanding. For more information and registration details, visit psychedelicscience.org, and follow us on X, Instagram, LinkedIn, and Facebook.

ABOUT MAPS
Founded in 1986, MAPS is a 501(c)(3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS' conference flagship, Psychedelic Science, has been the leading convening of the psychedelic community since 2010. MAPS incubated Lykos Therapeutics, a drug-development public benefit company, and the Zendo Project, a leader in psychedelic harm reduction. Since MAPS was founded, philanthropic donors and grantors have given more than $150 million to advance research, change drug policy, and evolve education in the field of psychedelics.

CONTACT
media@psychedelicscience.org


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.